BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Scope & Guideline
Exploring breakthroughs in bioorganic science.
Introduction
Aims and Scopes
- Drug Design and Discovery:
Research articles often delve into the rational design and synthesis of new drug candidates targeting various diseases, including cancer, infectious diseases, and neurodegenerative disorders. - Medicinal Chemistry Approaches:
The journal features studies employing cutting-edge medicinal chemistry techniques, including structure-activity relationship (SAR) studies, virtual screening, and computational modeling. - Biological Evaluation:
Acknowledging the importance of biological activity, the journal emphasizes the pharmacological evaluation of new compounds, assessing their efficacy and mechanisms of action in relevant biological models. - Natural Products and Derivatives:
Many publications explore the chemistry and bioactivity of natural products, examining their potential as lead compounds for drug development. - Innovative Synthesis Methods:
The journal promotes novel synthetic methodologies, including green chemistry approaches, microwave-assisted synthesis, and multi-component reactions, to enhance the efficiency of drug discovery.
Trending and Emerging
- PROTACs and Targeted Protein Degradation:
The rise of proteolysis-targeting chimeras (PROTACs) showcases a trend towards innovative strategies for targeted protein degradation, reflecting a shift in therapeutic approaches to modulate protein levels in disease contexts. - Immunotherapy and Checkpoint Inhibitors:
A growing number of studies are dedicated to the design of immune checkpoint inhibitors and immunotherapeutic agents, indicating a strong interest in leveraging the immune system for cancer treatment. - Nanoparticle and Drug Delivery Systems:
Research on novel drug delivery systems, including nanoparticles and liposomes, has gained traction, emphasizing the importance of improving bioavailability and targeting in therapeutic applications. - Natural Product Derivatives:
The exploration of modified natural products for their therapeutic potential continues to trend, with a focus on enhancing bioactivity and overcoming resistance mechanisms. - Machine Learning in Drug Discovery:
The integration of machine learning and artificial intelligence in drug discovery processes is emerging as a significant trend, aiding in the prediction of compound interactions and optimizing lead identification.
Declining or Waning
- Traditional Antibiotics:
There has been a noticeable decrease in the publication of studies focused on traditional antibiotic compounds, likely due to the rising challenge of antibiotic resistance and a shift towards alternative therapeutic strategies. - Single Target Inhibitors:
Research focusing solely on single-target inhibitors has waned as the field moves towards multi-target and combination therapies that may offer broader efficacy against complex diseases. - In vitro Studies Only:
There is a trend away from studies that solely rely on in vitro evaluations without subsequent in vivo validation, indicating a growing expectation for comprehensive pharmacological assessments.
Similar Journals
CURRENT MEDICINAL CHEMISTRY
Advancing the Frontiers of Medicinal Chemistry.Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.
BIOORGANIC & MEDICINAL CHEMISTRY
Unveiling Breakthroughs in Medicinal ChemistryBIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.
CURRENT ORGANIC SYNTHESIS
Unlocking the Secrets of Organic CompoundsCURRENT ORGANIC SYNTHESIS, published by Bentham Science Publishers Ltd, is a leading journal in the field of organic chemistry and biochemistry that serves as a vital platform for researchers and professionals advancing the synthesis of organic compounds. With an ISSN of 1570-1794 and an E-ISSN of 1875-6271, it boasts a significant impact within its category, ranked in the Q3 quartile for both biochemistry and organic chemistry as of 2023. The journal covers innovative research and reviews that enhance our understanding of organic synthesis methodologies, showcasing contributions that advance the field. Operating from Sharjah, United Arab Emirates, CURRENT ORGANIC SYNTHESIS has evolved since its inception in 2005, providing access to a wealth of information essential for students, professionals, and researchers alike. While it currently does not offer open access, the journal continues to maintain a strong community of scholars dedicated to fostering dialogue and innovation in the organic sciences.
HETEROCYCLES
Catalyzing Progress in Pharmacology and ChemistryHETEROCYCLES, published by the Japan Institute of Heterocyclic Chemistry, stands as a pivotal journal within the fields of Analytical Chemistry, Organic Chemistry, and Pharmacology. With its ISSN 0385-5414 and E-ISSN 1881-0942, HETEROCYCLES has been a respected platform for scholarly work since its establishment in 1983, featuring innovative research up until 2022. While currently not open access, the journal is renowned for its rigorous peer-review process, ensuring the dissemination of high-quality research. Despite its Q4 ranking in the 2023 quartiles for its categories, it plays a crucial role in bridging gaps in knowledge and advancing the discourse on heterocyclic compounds, which are vital in drug discovery and development. Researchers, professionals, and students who are engaged in chemistry and pharmacology will find HETEROCYCLES an essential source of cutting-edge studies, insights, and an opportunity to contribute to the evolving landscape of these scientific fields.
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY
Championing Excellence in Heterocyclic StudiesINDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, published by CONNECT JOURNALS, is a vital resource in the fields of organic chemistry and biochemistry, aiming to advance research and promote innovation within the realm of heterocyclic compounds. Established in 1996, this journal has successfully converged into an influential publication with a commitment to disseminating high-quality, peer-reviewed research articles that enhance the understanding of heterocyclic chemistry applications. Although it currently holds a Q4 quartile ranking in both biochemistry and organic chemistry according to the 2023 categorizations, its broader contributions to the scientific community should not be underestimated, as it seeks to support the ongoing dialogue among researchers, professionals, and students. The journal operates from Ghaziabad, India, providing open access to its publications, thereby fostering a collaborative and informative environment for its international readership. With an ISSN of 0971-1627 and a special focus on contemporary challenges and developments in the field, the INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY is poised to make a significant impact as it continues to evolve through 2024 and beyond.
TETRAHEDRON
Elevating scientific dialogue with rigorous peer-reviewed research.TETRAHEDRON, published by Pergamon-Elsevier Science Ltd, is a leading peer-reviewed journal that has been pivotal in advancing the fields of Biochemistry, Drug Discovery, and Organic Chemistry since its inception in 1957. With an ISSN of 0040-4020 and an E-ISSN of 1464-5416, this journal provides a platform for the dissemination of cutting-edge research and innovative methodologies that contribute significantly to the scientific community. Recognized for its rigorous editorial standards, TETRAHEDRON has been categorized in the Q3 quartile for 2023 across its relevant fields, reflecting its solid impact within the scientific sphere. Despite the current absence of Open Access options, the journal continues to engage a diverse readership, offering invaluable insights and advancements that fuel both academic and industrial applications. With an ongoing commitment to excellence, TETRAHEDRON remains an essential resource for researchers, professionals, and students aiming to stay at the forefront of chemistry and biochemistry research.
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN
Exploring innovative methodologies for a sustainable future.JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, published by the SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN, is an esteemed publication specializing in the dynamic field of organic chemistry. With a rich history dating back to 1944, this journal aims to disseminate pivotal research findings and innovative methodologies in synthetic organic chemistry, fostering collaboration and knowledge exchange among researchers and professionals. Although it currently holds a modest ranking in the Q4 quartile for organic chemistry, its commitment to advancing the discipline remains steadfast. The journal primarily caters to scholars and students seeking to delve deeper into organic synthesis, highlighting original articles, reviews, and methodological studies. While access to the journal is not open, its contributions to the field are essential for anyone invested in understanding the complexities of organic chemistry. We invite you to explore the journal's offerings and enhance your expertise in synthetic organic processes.
Records of Natural Products
Advancing Discoveries in Natural Product ScienceRecords of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.
SYNTHESIS-STUTTGART
Pioneering Research in Catalysis and Synthesis Since 1970.SYNTHESIS-STUTTGART
Published by the esteemed Georg Thieme Verlag KG, SYNTHESIS-STUTTGART stands as a vital resource in the field of Chemistry, specifically focusing on Organic Chemistry and Catalysis. With an impressive publication history dating back to 1970 and continuing through 2024, it serves as a platform for innovative research and developments in synthetic methodologies and their applications. The journal holds a significant impact factor, reflecting its influence within the academic community, and is recognized in the Scopus rankings as a reputable source in its categories, with a rank of #99/211 in Organic Chemistry and #43/68 in Catalysis. Researchers, professionals, and students alike can benefit greatly from its content, which upholds rigorous peer-review standards and contributes to the global discourse in these critical scientific domains.
RSC Medicinal Chemistry
Advancing the Frontiers of Medicinal InnovationRSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.